CHRO: Chromocell Therapeutics Corp. Company Short-Term Debt
Chromocell Therapeutics (CHRO) is developing an opioid-free pain management system by innovating the function of sodium channels. As reflected in the pakistan chart, the asset value on GURU.Markets is 0.00. Business development relies on synergy with clinical centers, while the success of primary trials enables the company to retain top-tier scientists and attract leading medical executives.
Analytical breakdowns for Chromocell (CHRO)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Debt to Equity Chromocell Therapeutics|CHRO - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Chromocell Therapeutics|CHRO - Company Cumulative Debt|Debt to Book Capitalization Ratio Chromocell Therapeutics Corp.|CHRO - Company Long-Term Liabilities|Company Short-Term Debt Chromocell Therapeutics|Quick Ratio chromocell.com
- net income and valuation multiples indicators:
Basic company analysis:CHRO - Chromocell Therapeutics Corp.
Chromocell Therapeutics (CHRO) invests in the development of non-opioid analgesics, meaning an analysis of its short-term debt portfolio allows for an assessment of the company's liquidity during a period of intensive R&D spending. This indicator aggregates all liabilities with a maturity of up to one year, where rising debt signals a risk of capital shortage, while its reduction confirms the asset's financial stability ahead of the official earnings release.
Competitor analysis
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|ACAD (ACADIA Pharmaceuticals) - Company Short-Term Debts|Company Current Liabilities xenon-pharma.com (XENE)|Company Short-Term Debts VKTX|SUPN (Supernus Pharmaceuticals, Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Catalyst Pharmaceuticals Inc CPRX|Company Short-Term Loans and Borrowings DNLI|HRMY - Company Short-Term Debt|Short-Term Debt biohavenpharma.com|Amylyx Pharmaceuticals, Inc. (AMLX) - Company Short-Term Debt|Company Current Liabilities Trevi Therapeutics Inc|Company Short-Term Debt Praxis Medicines|Short-Term Debt Anavex Life Sciences Corp AVXL|Company Short-Term Debts CBLL|Company Current Liabilities Prothena Corporation plc PRTA|Company Short-Term Debts ALEC (Alector)|Annexon Biosciences (ANNX) - Short-Term Debt|OMER - Company Short-Term Debt|NGNE: Company Short-Term Debt|AC Immune (ACIU) - Company Short-Term Debt|VYGR (voyagertherapeutics.com) - Company Short-Term Debt|Company Current Liabilities NMRA|SCLX: Company Short-Term Loans and Borrowings|Company Current Liabilities TVGN (Tevogen Bio Holdings, Inc.)|Amount of Current Liabilities ACOG|Company Short-Term Debts CGTX (Cognition Therapeutics, Inc.)|Company Short-Term Loans and Borrowings IKT|Cassava Sciences - Company Short-Term Debts|Short-Term Debt Assertio Holdings, Inc.|coyatherapeutics.com (COYA) - Company Short-Term Debt|Vistagen - Company Short-Term Loans and Borrowings|OVID (Ovid Therapeutics Inc) - Company Short-Term Debts|Company Short-Term Debts acumenpharm.com|Company Short-Term Debt CervoMed (CRVO)|ATHE: Current Liabilities|Company Short-Term Debts CLNN (Clene)|PepGen Inc (PEPG) - Short-Term Debt|JUNS: Company Current Liabilities|RLMD - Company Short-Term Debts|ANVS (Annovis Bio) - Company Current Liabilities|GRCE: Amount of Current Liabilities|AIFF (Firefly Neuroscience Inc) - Company Short-Term Debts|ANEW Medical, Inc. (KLTO) - Short-Term Debt Volume|Company Short-Term Debts NRSN|Company Current Liabilities revivapharma.com RVPH|Company Short-Term Debt MetaVia MTVA|Short-Term Debt Volume NeurAxis Inc. (NRXS)|Helius Medical Technologies Inc. - Company Short-Term Debts|Passage Bio, Inc. (PASG) - Company Current Liabilities|NEUP: Company Short-Term Debts|minervaneurosciences.com - Company Short-Term Loans and Borrowings|Company Short-Term Debt Athira Pharma|ADXN: Company Short-Term Loans and Borrowings|Company Short-Term Debt Alzamend Neuro, Inc. (ALZN)|CYCN - Short-Term Debt|Company Short-Term Debt Protagenic Therapeutics, Inc. PTIX|KTTA: Company Short-Term Indebtedness|Cortigent Medical - Company Short-Term Debts|Short-Term Debt Avenue Therapeutics Inc.|BCLI (Brainstorm Cell Therapeutics, Inc.) - Company Current Liabilities|Cara Therapeutics Inc (CARA) - Company Short-Term Debts|Company Short-Term Debt Eliem Therapeutics, Inc.|ITCI: Company Short-Term Loans and Borrowings|Company Short-Term Debt Longboard Pharmaceuticals, Inc. (LBPH)|MRNS - Short-Term Debt|Company Short-Term Debts NKGN (NKGen)|NRBO - Company Current Liabilities|Sage Therapeutics, Inc. - Company Short-Term Debts|Company Short-Term Loans and Borrowings SNPX (synaptogen.com)|Trevena (TRVN) - Company Short-Term Debt|Vigil Neuroscience, Inc. - Company Short-Term Loans and Borrowings|Company Short-Term Debt Anew Medical, Inc.|Short-Term Debt Cerevel Corp CERE